227 related articles for article (PubMed ID: 19536025)
1. Completing costs: patients' time.
Russell LB
Med Care; 2009 Jul; 47(7 Suppl 1):S89-93. PubMed ID: 19536025
[TBL] [Abstract][Full Text] [Related]
2. Costing and perspective in published cost-effectiveness analysis.
Neumann PJ
Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
[TBL] [Abstract][Full Text] [Related]
3. Indirect cost in economic evaluation: the opportunity cost of unpaid inputs.
Posnett J; Jan S
Health Econ; 1996; 5(1):13-23. PubMed ID: 8653189
[TBL] [Abstract][Full Text] [Related]
4. Panel on cost-effectiveness in health and medicine recommendations: identifying costs.
Manning WG
J Clin Psychiatry; 1999; 60 Suppl 3():54-6; discussion 57-8. PubMed ID: 10073379
[TBL] [Abstract][Full Text] [Related]
5. An improved set of standards for finding cost for cost-effectiveness analysis.
Barnett PG
Med Care; 2009 Jul; 47(7 Suppl 1):S82-8. PubMed ID: 19536018
[TBL] [Abstract][Full Text] [Related]
6. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
Hoerger TJ
Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
[TBL] [Abstract][Full Text] [Related]
7. Administrative and claims records as sources of health care cost data.
Riley GF
Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
[TBL] [Abstract][Full Text] [Related]
8. "An overview of the NHEA with implications for cost analysis researchers".
Heffler S; Nuccio O; Freeland M
Med Care; 2009 Jul; 47(7 Suppl 1):S37-43. PubMed ID: 19536011
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
10. Health care costing: data, methods, current applications.
Lipscomb J; Yabroff KR; Brown ML; Lawrence W; Barnett PG
Med Care; 2009 Jul; 47(7 Suppl 1):S1-6. PubMed ID: 19536004
[No Abstract] [Full Text] [Related]
11. Costing of severe pneumonia in hospitalized infants and children aged 2-36 months, at a secondary and tertiary level hospital of a not-for-profit organization.
Madsen HO; Hanehøj M; Das AR; Moses PD; Rose W; Puliyel M; Konradsen F; John KR; Bose A
Trop Med Int Health; 2009 Oct; 14(10):1315-22. PubMed ID: 19719464
[TBL] [Abstract][Full Text] [Related]
12. Economic costs of drug abuse: financial, cost of illness, and services.
Cartwright WS
J Subst Abuse Treat; 2008 Mar; 34(2):224-33. PubMed ID: 17596904
[TBL] [Abstract][Full Text] [Related]
13. Design and analysis issues for economic analysis alongside clinical trials.
Marshall DA; Hux M
Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
[TBL] [Abstract][Full Text] [Related]
14. Adjusting to changes in health: implications for cost-effectiveness analysis.
Sharma R; Stano M; Haas M
J Health Econ; 2004 Mar; 23(2):335-51. PubMed ID: 15019760
[TBL] [Abstract][Full Text] [Related]
15. Trends in cost effectiveness analyses in orthopaedic surgery.
Brauer CA; Neumann PJ; Rosen AB
Clin Orthop Relat Res; 2007 Apr; 457():42-8. PubMed ID: 17242614
[TBL] [Abstract][Full Text] [Related]
16. Superbugs: should antimicrobial resistance be included as a cost in economic evaluation?
Coast J; Smith RD; Millar MR
Health Econ; 1996; 5(3):217-26. PubMed ID: 8817296
[TBL] [Abstract][Full Text] [Related]
17. [Obesity and health economics. Review and status].
Pedersen KM; Worre-Jensen AL
Ugeskr Laeger; 2006 Jan; 168(2):196-201. PubMed ID: 16403351
[TBL] [Abstract][Full Text] [Related]
18. What are the costs of childhood-onset rheumatic disease?
Minden K
Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):223-40. PubMed ID: 16546054
[TBL] [Abstract][Full Text] [Related]
19. Methods to estimate and analyze medical care resource use. An example from liver transplantation.
Katz PP; Showstack JA; Lake JR; Brown RS; Dudley RA; Colwell ME; Wiesner RH; Zetterman RK; Everhart J
Int J Technol Assess Health Care; 1999; 15(2):366-79. PubMed ID: 10507195
[TBL] [Abstract][Full Text] [Related]
20. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.
Tate JE; Rheingans RD; O'Reilly CE; Obonyo B; Burton DC; Tornheim JA; Adazu K; Jaron P; Ochieng B; Kerin T; Calhoun L; Hamel M; Laserson K; Breiman RF; Feikin DR; Mintz ED; Widdowson MA
J Infect Dis; 2009 Nov; 200 Suppl 1():S76-84. PubMed ID: 19817618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
